The Use of Benzodiazepines in Organophosphorus Nerve Agent Intoxication

Chemical Warfare Agents: Toxicology and Treatment, Second Edition

Volumn , Issue , 2007, Pages 331-342

  Marrs, Timothy C ^a,b,c   Sellström, Åke ^d  

^a Edentox Associates   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^d Swedish Defence Agency   (Sweden)

Author keywords

Benzodiazepine dose recommendation; Benzodiazepine use in nerve agent intoxication; Diazepam and avizafone in sarin induced neuropathology; Diazepam and nerve agents; Lorazepam efficacy in status epilepticus

Indexed keywords

EID: 84881562013     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470060032.ch16     Document Type: Chapter

References (91)

1. Allison C and Pratt JA (2003). Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence. Pharmacol Ther, 98, 171-195.
2. Andreasen PB, Hendel J, GreisenGet al. (1976). Pharmacokinetics of diazepam in disordered liver function. Eur J Clin Pharmacol, 10, 115-120.
3. Baldessarini RJ (1980). Drugs and the treatment of psychiatric disorders. In: Goodman and Gilman's, the Pharmacological Basis of Therapeutics (AG Gilman, LS Goodman andAGilman, eds), pp. 391-447. New York, NY, USA: Macmillan.
4. Barckow D, Neuhaus G and Erdmann WD (1969). Zur Behandlung der schweren Parathion-(E 605)-Vergiftung mit dem Cholinesterase-Reaktivator Obidoxim (Toxogonin). Arch Toxicol, 24, 133-146.
5. Barr MA (1964). Poisoning by anticholinesterase organic phosphates: it significance in anaesthesia. Med J Aust, 00, 792-796.
6. Barr MA (1966). Further experience in the treatment of severe organic phosphate poisoning. Med J Aust, 00, 490-492.
7. Blumer JL (1998). Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet, 35, 37-47.
8. Bokonjić D, Jovanović D, Jokanović M et al. (1987). Protective effects of oximes HI-6 and PAM-2 applied by osmotic minipumps in quinalphospoisoned rats. Arch Int Pharmacodyn Ther, 288, 309-318.
9. Bošković B (1981). The treatment of soman poisoning and its perspectives. Fund Appl Toxicol, 1, 203-213.
10. Bošković B, Kovačević V and Joanović D (1984). PAM-Cl, HI-6, and HGG-12 in soman and tabun poisoning. Fund Appl Toxicol, 4, S106-S115.
11. Capacio BR, Whalley CE, Byers CE et al. (2001). Intramuscular diazepam pharmacokinetics in somanexposed guinea pigs. J Appl Toxicol, 21, S67-S74.
12. Chamberlain JM, Altieri MA, Futterman C et al. (1997). A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care, 13, 92-94.
13. Charney DS, Mihic SJ and Harris RA (2001). Hypnotics and sedatives. In: Goodman and Gilman's, the Pharmacological Basis of Therapeutics, 10th Edition, pp. 399-427. New York, NY, USA: McGraw-Hill.
14. Churchill L, Padzernik TL, Cross RS et al. (1987). Cholinergic systems influence local cerebral glucose use in specific anatomical areas diisopropyl phosphorofluoridate versus soman. Neuroscience, 20, 329-340.
15. Clement JG and Broxup B (1993). Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats. Neurotoxicology, 14, 485-504.
16. Costa E and Guidotti A(1979). Molecular mechanisms in the receptor actions of benzodiazepines. Ann Rev Pharmacol Toxicol, 19, 531-545.
17. De Kort WM, Kiestra SH and Sangster B (1988). The use of atropine and oximes in OP intoxications: a modified approach. Clin Toxicol, 26, 199-208.
18. Department of Health,UK(2005). Pre-hospital guidelines for the emergency treatment of deliberate release of organophosphorus (OP) nerve agents. London, UK: Department of Health (www.dh.uk/policyAndGuidance/EmergencyPlanning/DeliberateReleaseChemical).
19. Diamantis W and Kletzkin M (1966). Evaluation of muscle relaxant drugs by head-drop and by decerebrate rigidity. Int J Neuropharmacol, 5, 305-310.
20. Doebler JA,Wall TJ, Martin LJ et al. (1985). Effects of diazepam on soman-induced brain neuronal RNA depletion and lethality in rats. Life Sci, 36, 1107-1115.
21. Drislane FW (1997). Status epilepticus. In: The Comprehensive Evaluation and Treatment of Epilepsy (SC Schachter andDLSchomer, eds), pp. 149-172. San Diego, CA, USA: Academic Press
22. Gupta RC (1984). Acute malathion toxicosis and related enzymatic alterations in Bubulus bubalis: antidotal treatment with atropine, 2-PAM, and diazepam. J Toxicol Environ Health, 14, 291-303.
23. Haigh JR and Feely M (1988). Tolerance to the anticonvulsant effect of benzodiazepines. Trends Pharmacol Sci, 9, 361-366.
24. Hillestad L, Hansen T, Melsom H et al. (1974). Diazepam metabolism in normal man 1. Serumconcentrations and clinical effects after intravenous, intramuscular, and oral administration. Clin Pharm Therap, 16, 479-484.
25. Hopmann G and Wanke H (1974). (Maximum dose atropine treatment in severe organophosphate poisoning). (Author's translation)). Dtsch Med Wochenschr, 99, 2106-2108.
26. Hvidberg EF and Dam M (1976). Clinical pharmacokinetics of anticonvulsants. Clin Pharmacokin, 1, 161-188.
27. Inns RH and Leadbeater L (1983). The efficacy of bispyridinium derivatives in the treatment of organophosphate poisoning in the guinea-pig. J Pharm Pharmacol, 35, 427-433.
28. Johnson DD and Lowndes HE (1974). Reduction by diazepam of repetitive electrical activity and toxicity resulting from soman. Eur J Pharmacol, 28, 245-250.
29. Johnson DD and Wilcox WC (1975). Studies on the mechanism of the protective and antidotal actions of diazepam in organophosphate poisoning. Eur J Pharmacol, 34, 127-132.
30. Johnson MK and Vale JA (1992). Clinical management of acute organophosphate poisoning: an overview. In: Clinical and Experimental Toxicology of Organophosphates and Carbamates, (B Ballantyne andTCMarrs, eds), pp. 528-535. Oxford, UK: Butterworth-Heinemann.
31. Johnston GAR (1996). GABAA receptor pharmacology. Pharmacol Ther, 69, 173-198.
32. Jones DM, Esmaeil N, Maren S et al. (2002). Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res, 50, 301-312.
33. Jovanović D, Randjelović S and Joksović DC (1990). A case of unusual suicidal poisoning by the organophosphorus insecticide, dimethoate. Human Exp Toxicol, 9, 49-51.
34. Karalliedde L and Szinicz L (2001). Management of organophosphorus compound poisoning. In: Organophosphates and Health (L Karalliedde, S Feldman, J Henry et al., eds), pp. 257-293. London, UK: Imperial College Press.
35. Karlsson B, Lindgren B, Millquist E et al. (1990). On the use of diazepam and pro-diazepam (2-benzoyl-4-chloro-N-methyl-N-lysylglycin anilide), as adjunct antidotes in the treatment of organophosphorus intoxication in the guinea-pig. J Pharm Pharmacol, 42, 247-251.
36. Kassa J (2002). Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agent. J Toxicol Clin Toxicol, 40, 803-816.
37. Kassa J and Bajgar J (1994).Treatment of Stressogenic Effect of Dichlorvos. Treatment of Stressogenic effect of dichlorvous. Sb Ved Pr Lek Fak Karlovy, Univerzity Hradci Králove, Czech Republic.
38. Kleinrok Z and Jagiełło-Wojtowicz E (1977). Wptyw wybranych lekow przeciwpadaczkowych na toksycznosc ostra estra dwuizopropylowego kwasu fluorofosforowego u myszy. Ann Univers Mariae Curie-Skłodowska, 34, 127-132.
39. Klotz U, Avant GR, Hoyumpa A et al. (1975). The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest, 55, 347-359.
40. Klotz U, Antonin KH and Bieck PR (1976a). Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J Pharmacol Exper Therap, 199, 67-73.
41. Klotz U, Antonin KH and Bieck PR (1976b). Comparison of the pharmacokinetics of diazepam after single and subchronic doses. Eur J Clin Pharmacol, 10, 121-126.
42. Krutak-Krol H and Domino EF (1985). Comparative effects of diazepam and midazolam on paraoxon toxicity in rats. Toxicol Appl Pharmacol, 81, 545-550.
43. Kulkarni YD, Sharma VL, Dua PR et al. (1982). Substituted benzophenones as possible anticonvulsants and tranquillizers. Ind J Pharm Sci, 44, 1-4.
44. Kusić R, Jovanović D, Randjelović S et al. (1991). H-6 in man: efficacy of the oxime in poisoning by organophosphorous insecticides. Human Exp Toxicol, 10, 113-118.
45. Lallement G, Clarencon D, Brochier G et al. (1997). Efficacy of atropine/pralidoxime/diazepam or atropine/HI-6/prodiazepam in primate intoxicated by soman. Pharmacol Biochem Behav, 56, 325-332.
46. Lallement G, Renault F, Baubichon D et al. (2000). Compared efficacy of diazepam or avizafone to prevent soman-induced electroencephalographic disturbances and neuropathology in primates: relationship to plasmic benzodiazepine pharmacokinetics. Arch Toxicol, 74, 480-486.
47. Lallement G, Masqueliez C, Baubichon D et al. (2004). Protection against soman-induced lethality of the antidote combination atropine-pralidoxime-pro-diazepam packed as a freeze-dried form. J Med Chem Def, 2, 1-11.
48. LeBlanc FN, Benson BE and Gilg AD(1986).Asevere organophosphate poisoning requiring the use of an atropine drip. Clin Toxicol, 24, 69-76.
49. Lipp JA (1972). Effect of diazepam upon somaninduced seizure activity and convulsions. Electroenceph Clin Neurophys, 32, 557-560.
50. Lipp JA (1973). Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsionsin the monkey. Arch Int Pharmacodyn Ther, 202, 244-251.
51. Lipp JA (1974). Effect of small doses of clonazepam upon soman-induced seizure activity and convulsions. Arch Int Pharmacody Ther, 210, 49-54.
52. Livezey GT, Marczynski TJ and Isaac L (1986). Enduring effects of prenatal diazepam on the behavior, EEG and brain receptors of the adult cat progeny. Neurotoxicology, 7, 319-334.
53. Lüddens H and Korpi ER (1995). Biological functions of GABAA/benzodiazepine receptor heterogeneity. J Psychiatr Res, 29, 77-94.
54. Lundy PM, Magor G and Shaw RK (1978). Gamma aminobutyric acid metabolism in different areas of rat brain at the onset of soman-induced convulsions. Arch Int Pharmacodyn, 234, 64-73.
55. Maidment MP and Upshall DG (1990). Pharmacokinetics of the conversion of peptideaminobenzophenone pro-drug of diazepam in guinea-pig and rhesus monkeys. J Biopharm Sci, 1, 19-32.
56. Mandelli M, Tognoni G and Garattini S (1978). Clinical pharmacokinetics of diazepam. Clin Pharmacokin, 3, 72-91.
57. Marrs TC (2003). Diazepam in the treatment of organophosphorus ester pesticide poisoning. Toxicol Rev, 22, 75-81.
58. Marrs TC (2004). The role of diazepam in the treatment of nerve agent poisoning in a civilian population. Toxicol Rev, 23, 145-157.
59. Marti J, Reverte C, Roig M et al. (1985). Uso del diacepam en la intoxicacion por insecticidas organofosforados. An Esp Pediatr, 23, 299-301.
60. Martin LJ, Doebler JA, Shih T-M et al. (1985). Protective effect of diazepam pretreatment on somaninduced brain lesion formation. Brain Res, 325, 287-289.
61. Martire M, Altobello D, Cannizzaro C et al. (2002). Prenatal diazepam exposure functionally alters the GABAA receptor that modulates [3H] noradrenaline release from rat hippocampal synaptosomes. Dev Neurosci, 24, 71-78.
62. Mattila MA, Suurinkeroinen S, Saila K et al. (1983). Midazolam and fat-emulsion diazepam as intramuscular premedication. A double-blind clinical trial. Acta Anaesthesiol Scand, 27, 345-348.
63. Mazarati AM, Baldwin RA, Sankar R et al. (1998). Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of selfsustaining status epilepticus. Brain Res, 814, 179-185.
64. McDonough JH, Dochterman LW, Smith CD et al. (1995). Protection against nerve agent induced neuropathology, but not cardiac pathology, is associated with anticonvulsant action of drug treatment. Neurotoxicology, 16, 123-132.
65. McDonough JH, McMonagle J, Copeland T et al. (1999). Comparative evaluation of benzodiazepines for control of soman-induced seizures. Arch Toxicol, 73, 473-478.
66. McEllhatton PR (1994). The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol, 8, 461-475.
67. Menzel G, Wessel. G (1962b). Beitrag zur Toxikologie der Alkylphosphate. Dtsch Gesundheitsw, 17, 1297-I304.
68. Merrill DG and Mihm FG (1982). Prolonged toxicity of organophosphate poisoning. Crit Care Med, 10, 550-551.
69. Morselli PL, Cassano GB, Placidi GF et al. (1974). Kinetics of the distribution of 14C-diazepam and its metabolites in various areas of cat brain. In: The Benzodiazepines (S Garattini, E Mussini and LO Randall, eds), pp. 259-270. New York, NY, USA: Raven Press.
70. Okumura T, Takasu N, Ishimatsu S et al. (1996). Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med, 28, 129-135.
71. Ortells MO and Lunt GG (1995). Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci, 18, 121-127.
72. Pazdernik TL, Nelson SR, Cross R et al. (1986). Effects of antidotes on soman-induced brain changes. Arch Toxicol (Supplement), 9, 333-336.
73. Pieri L, Schaffner R, Scherschlicht R et al. (1981). Pharmacology of midazolam. Arzneim-Forsch, 31, 2180-2201.
74. Reves JG, Fragen RJ, Vinik HR et al. (1985). Diazepam: pharmacology and uses. Anesthesiology, 62, 310-324.
75. Rosenow F, Arzimanoglou A and Baulac M (2002). Recent developments in treatment of status epilepticus: a review. Epileptic Disord (Supplement 2), S41-S51.
76. Rotenberg JS and Newmark J (2003). Nerve agent attacks on children: Diagnosis and management. Pediatrics, 112, 648-658.
77. Rump S and Grudzinska E (1974). Investigations on the effects of diazepam in acute experimental intoxications with fluostigmine. Arch Toxikol, 31, 223-232.
78. Rump S, Grudzinska E and Edelwejn Z (1973). Effects of diazepam on epileptiform patterns of bioelectrical activity or the rabbit's brain induced by fluostigmine mine. Neuropharmacology, 12, 813-817.
79. Rump S, Faff J, Szymanska T et al. (1976). Efficacy of repeated pharmacotherapy in experimentalacute poisonings with fluostigmine. Arch Toxicol, 35, 275-280.
80. Ryan CL and Pappas BA (1986). Intrauterine diazepam exposures: effects on physical and neurobehavioral development in the rat. Neurobehav Toxicol Teratol, 8, 279-286.
81. Sellström A (1992). Anticonvulsants in anticholinesterase poisoning. In: Clinical and Experimental Toxicology of Organophosphates and Carbamates (B Ballantyne and TC Marrs, eds), pp. 578-586. Oxford, UK: Butterworth-Heinemann.
82. Shih TM, Duniho SM and McDonough JH (2003). Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol, 188, 69-80.
83. SieghartWand Sperk G (2002). Subunit composition, distribution and function of GABAA receptor subtypes. Curr Top Medicinal Chem, 2, 795-816.
84. Silva FR and Palermo-Neto J (1999). Developmental, neuro and immunotoxic effect of perinatal diazepam treatment in rats. Immunopharmacol Immunotoxicol, 21, 247-265.
85. Solberg Y and Belkin M (1997). The role of exitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol Sci, 18, 183-185.
86. Stoeckel H and Meinecke KH (1966). (On a case of occupational poisoning by mevinphos). (Author's translation). Arch Toxikol, 21, 284-288.
87. Taysse L, Calvet JH, Buee J et al. (2003). Comparative efficacy of diazepam and avizafone against sarininduced neuropathology and respiratory failure in guinea pigs; influence of atropine dose. Toxicology, 188, 197-209.
88. Vale JA and Scott GW(1974). Organophosphorus poisoning. Guy's Hosp Rep, 123, 13-25.
89. van der Kleijn E, van Rossum JM, Muskens ETJM et al. (1971). Pharmacokinetics of diazepam in dogs, mice and humans. Acta Pharmacol Toxicol, 29, 109-127.
90. Viani A, Rizzo G, Carrai M et al. (1992). The effects of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. Br J Clin Pharmacol, 33, 299-304.
91. Yacoub M, Skouri H, Amamou M et al. (1981). Intoxications aigües par les insecticides organophosphor é. J Toxicol Med, 1, 165-188.